* Bioceres Crop Solutions Corp BIOX.OQ BIOX.O is expected
to show a rise in quarterly revenue when it reports results on
September 9.
* The Rosario, Santa Fe-based company is expected to report a
12.0% increase in revenue to $53.929 million from $48.16 million
a year ago, according to the mean estimate from 4 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Bioceres Crop Solutions
Corp is for earnings of 27 cents per share. For the same quarter
last year, the company reported earnings of 6 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for Bioceres Crop
Solutions Corp is $18.8, about 25.8% above its last closing
price of $13.95.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Mar. 31 2021 -0.05 -0.05 -0.03 Beat 38
Dec. 31 2020 0.36 0.36 0.02 Missed -95.3
Sep. 30 2020 0.08 0.08 -0.19 Missed -337.5
Jun. 30 2020 0.22 0.22 0.06 Missed -72.1
Mar. -0.12 -0.11 -0.09 Beat 21.7
31 2020
Dec. 31 2019 0.33 0.33 0.31 Missed -6.1
This summary was machine generated September 7 at 11:04 GMT.
All figures in US dollars unless otherwise stated